Form 8-K - Current report:
SEC Accession No. 0001193125-25-304067
Filing Date
2025-12-01
Accepted
2025-12-01 17:13:01
Documents
12
Period of Report
2025-12-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d48096d8k.htm   iXBRL 8-K 23892
  Complete submission text file 0001193125-25-304067.txt   137458

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20251201.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20251201_lab.xml EX-101.LAB 17992
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20251201_pre.xml EX-101.PRE 11263
14 EXTRACTED XBRL INSTANCE DOCUMENT d48096d8k_htm.xml XML 3628
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 251540645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)